Skip to content

Clinical trials

Phase 3 Weight Gain trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20052
20072
20082
20101
20112
20131
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Augusta University1
Eli Lilly and Company1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Harvard School of Public Health (HSPH)1
Kirby Institute1
Lindner Center of HOPE1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Nationwide Children's Hospital1
Northwestern University1
Odense University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain16
Diabetes Mellitus, Type 24
Obesity4
Acquired Immunodeficiency Syndrome1
Anorexia Nervosa1
Bipolar Disorder1
Body Weight1
Bronchiolitis Obliterans Syndrome1
Diabetes Mellitus1
Edema1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.